By now there is a large body of evidence that psychosocial factors can be considered common risk factors in heart disease and significantly deteriorate patientreported outcomes, such as health-related quality of life in general. 1, 2 One of these psychosocial factors is anxiety, whether anxiety symptoms or anxiety disorders. While depression research in heart disease has received significantly high priority, research on anxiety and cardiovascular disease has received less priority. 3 Despite an ongoing debate on the role of anxiety symptoms and anxiety disorders for heart disease in general, 4 anxiety symptoms and anxiety disorders in patients with an implanted cardioverter defibrillator (ICD) present an increased risk in mortality compared to patients without anxiety disorders. 5 Several pathways, such as behavioural or biological mechanisms, relating to how mental health and heart disease are linked, have been discussed in the literature for both men and women in studies such as that of Vaccarino and Bremner. 6 However, despite being associated with the risk of mortality in patients with ICD, anxiety disorder is a disease in its own right (not a comorbidity per se), which is reflected in the diagnostic schema such as the International classification of diseases (ICD-11) 7 or the Diagnostic and statistical manual of mental disorders 5. 8 Hence, it is important to accurately diagnose the mental health status of any patient and to prescribe evidence-based interventions such as cognitive behavioural therapy (CBT) or pharmacology 1 if necessary, also to establish if mental health status presents as a co-morbidity or is considered a risk factor.
In this issue of the Journal of Preventive Cardiology, Berg et al. 9 present the results of a randomised trial, comparing CBT to usual care in patients with an ICD for reducing symptoms of anxiety. Clinical trials on psychological interventions are particular difficult to carry out, as the classical double-blind design is hard to achieve. Unique in this study, was that the authors initially screened for anxiety symptoms and disorders and identified types of anxiety using structured clinical interview for DSM disorders (SCID)-interviews. Patients (n ¼ 88) were randomised on a 1:1 basis and either received usual care with CBT (n ¼ 44) or just usual care (n ¼ 44). CBT techniques such as: analysis of the problem, psycho-education, restructuring of negative automatic thoughts, behavioural experiments and home assignments were carried out by trained nurses who were supervised by a mental health specialist, a psychologist. The authors were able to demonstrate in the trial that CBT treatment on top of usual care reduces the level of symptoms of anxiety and this reduction represented a large clinical effect (d ¼ -0.86).
Overall the results are very promising for ICD patients presenting with anxiety disorders or symptoms of anxiety indicating that there is a safe evidence-based intervention (CBT) readily available to elevate symptoms. However, some questions in particular for clinical routine remain. For example, how can policy makers assist in ensuring that screening for mental health in cardiac patients in general, and ICD patients in particular, becomes part of clinical routine? It is largely unclear why this has not yet translated into routine clinical practice worldwide with such clear scientific evidence for the impact of mental health in patients with cardiovascular disease and the impact of cardiovascular disease on the mental health status of a patient. Second, who should perform mental health screening or implement mental health intervention programmes? Like the Berg et al. 9 study, it was feasible to carry out CBT interventions with trained nurses supervised by experienced psychologists. From a patient's perspective it becomes less intrusive if medical personal with an established patient-relationship (such as medical doctors or qualified nurses) perform screening for mental health issues on a routine basis. With culturally adopted, internationally available psychometrically validated screening tools, there are no technical restrictions in implementing screening for mental health. 10 With technological advancements such as electronic patient surveys, mHealth applications etc., even fewer barriers exist today than just some years ago, as shown, for example, by the study of Gidding et al. 11 If the results of the screening procedure are positive or other indicators arise, a mental health professional (for example a psychologist or psychiatrist) must be involved to accurately diagnose and prescribe treatment.
Trials of high methodological quality like that of Berg et al. 9 may serve as role models for future clinical trials investigating treatment strategies to reduce symptoms of anxiety or treat anxiety disorders in patients with ICDs. Equally important by now is, how to transfer these evidence-based results into clinical routine practice, making sure patients receive available, safe and evidence-based treatment options for their conditions on a routine basis.
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